How to Buy Palvella Therapeutics Stock
Palvella Therapeutics Inc
Pieris Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs.
Palvella Therapeutics stock last closed at $13.97, down 1.96% from the previous day, and has increased 2.06% in one year. It has overperformed other stocks in the Biotechnology industry by 0.37 percentage points. Palvella Therapeutics stock is currently +125.32% from its 52-week low of $6.20, and -37.41% from its 52-week high of $22.32.
There are currently 1.32M PVLA shares outstanding. The market cap of PVLA is $18.44M. In the last 24 hours, 25,244 PVLA shares were traded.
How to Buy Palvella Therapeutics Stock
Not sure how to invest in Palvella Therapeutics stock? Here's how.
- Figure out where to buy Palvella Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you choose where to buy Palvella Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your investment account: Select your payment method and add your info.
- Analyze Palvella Therapeutics stock: The Palvella Therapeutics ticker symbol is PVLA. Is Palvella Therapeutics stock a good investment? Should you buy shares of PVLA? How do PVLA's underlying business fundamentals look? Do top analysts think Palvella Therapeutics is a good buy? Why has PVLA's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if PVLA is a good stock to buy).
- Make your PVLA purchase: Decide if you will purchase PVLA shares at the current market price or use a limit order to purchase PVLA shares at a particular price.
- Get the latest scoop on your investment in PVLA: Create a watchlist to monitor your investment in Palvella Therapeutics shares.
Step 1: Figure out where to buy Palvella Therapeutics stock
You will need a brokerage account in order to access the NASDAQ market and buy PVLA shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro now.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal information so you can buy PVLA today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start your new trading account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've opened your account on the best stock trading app for beginners, your next step is to transfer the money for your investment:
Watch the tutorial below for more details transferring funds into your brokerage account.
Step 4: Analyze Palvella Therapeutics stock
Once you have selected the best place to buy Palvella Therapeutics stock, it's crucial to analyze their stock before you invest, so you truly understand the risk and opportunity.
Palvella Therapeutics Numbers
PVLA Overview
WallStreetZen was designed to help part-time investors perform better fundamental analysis in less time.
You can see all of the due diligence checks on PVLA's stock page.
How is PVLA stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PVLA's fair value.
Using relative valuations ratios:
- PVLA could be undervalued based on its P/B ratio of 1.13x, relative to Biotechnology industry P/B ratio of 4.88x
You can access additional valuation analysis on PVLA's stock here.
PVLA Financials at a glance
Positive Financial Indicators:
- Total PVLA debt is lower than 5 years ago, relative to shareholder equity.
- PVLA has a low debt to equity ratio of 0.26.
- There are more short-term assets than short-term liabilities on the PVLA balance sheet.
- There are more short-term assets than long-term liabilities on the PVLA balance sheet.
Negative Financial Indicators:
- PVLA profit margin has gone down from -59.3% to -1,180% in the past year.
- PVLA has $19.36M in cash and short term investments. This is not sufficient to cover its annual cash burn of $25.67M.
- PVLA has cash burn of 25668000. It does not have sufficient cash and short-term investments to cover this.
Do analysts think it's a good time to buy PVLA stock
Out of 1 Wall Street analysts who research PVLA, the consensus analyst rating on Palvella Therapeutics is a Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Palvella Therapeutics stock forecast page.
PVLA Technicals
PVLA Performance Numbers
Last year, PVLA revenue was $1.35M. During the past 5 year, PVLA's revenue has gone up by -47.51% per year. This was slower than the Biotechnology industry average of 61.97%.
Learn more about PVLA's earnings and revenue performance here.
Who is buying/selling PVLA?
In the last year, executives and large shareholders at PVLA have bought more shares than they have sold.
George M. Jenkins, Director of PVLA, was the latest PVLA insider to buy. They bought $51,720.00 worth of PVLA stock on Dec 18, 2024.
Dig into more about who owns PVLA stock here.
Does PVLA provide a stable income stream?
No, Palvella Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about PVLA
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your PVLA purchase
There are two primary options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly fine. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact dollar amount, place a limit order.
Hit the Open button and your broker will place the order.
If you require additional info about investing in stocks on eToro, watch the helpful video below:
Step 6: Get the latest scoop on your investment in PVLA
Now that you own some shares in PVLA, you'll want to stay up-to-date on your new stock purchase.
Make a watchlist to track your PVLA stock.
PVLA Feed
How to Buy Stock in Palvella Therapeutics
To reiterate, here are the 6 steps for buying Palvella Therapeutics stock:
- Figure out where to buy Palvella Therapeutics stock
- Open your brokerage account
- Deposit money your investment account
- Analyze Palvella Therapeutics stock
- Make your PVLA purchase
- Get the latest scoop on your investment in PVLA
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to get the latest news on your investment in Palvella Therapeutics, add PVLA to your watchlist below.
More Content You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.